Records containing: Pure Red Cell Aplasia
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2024-12-10A Phase II Pilot Study of Nonmyeloablative Conditioning Hematopoietic Stem Cell Transplantation in Children with Sickle Cell Disease Who Have a Matched Related Major ABO-Incompatible Donor (Sickle-AID)
-
CLINICAL_TRIALS study record update · 2023-10-04National Registry of Rare Kidney Diseases (RaDaR)
-
CLINICAL_TRIALS study record update · 2022-12-14Phase I/II, Open Label Study to Determine Safety of Trifluoperazine (TFP) in Adults With Red Blood Cell Transfusion-Dependent Diamond Blackfan Anemia
-
CLINICAL_TRIALS study record update · 2022-12-02The Use of Novel Therapies to Reconstitute Blood Cell Production and Promote Organ Performance Using Bone Marrow Failure as a Model: a Pilot, Phase I/II Study of the Amino Acid Leucine in the Treatment of Patients With Transfusion-Dependent Diamond Blackfan Anemia
-
CLINICAL_TRIALS study record update · 2021-07-06Sirolimus Treatment for Refractory Pure Red Cell Aplasia, a Prospective Study
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2019-12-03Tacrolimus Treatment for Refractory Autoimmune Cytopenia
-
CLINICAL_TRIALS study record update · 2019-03-14An Open-Label Study to Investigate the Efficacy and Safety of AF37702 Injection in the Treatment of Anemia Caused by Antibody-Mediated Pure Red Cell Aplasia in Patients With Chronic Kidney Disease
-
CLINICAL_TRIALS study record update · 2018-05-30Tacrolimus Treatment for Refractory Pure Red Cell Aplasia, a Prospective Study
-
CLINICAL_TRIALS study record update · 2015-05-14A Pilot Study of Recombinant Humanized Anti-Interleukin (IL-2) Receptor Antibody (Daclizumab) in Patients With Moderate Aplastic Anemia, Pure Red Cell Aplasia, or Diamond Blackfan Anemia
-
CLINICAL_TRIALS study record update · 2013-11-11Allogeneic Mixed Chimerism Stem Cell Transplantation Utilizing In Vivo and In Vitro Campath for Hemoglobinopathies and Bone Marrow Failure Syndromes